FDA's suggestion of maximal use trials to assess the systemic absorption potential for proposed sunscreen ingredients will delay consumer access to new broad-spectrum sunscreens without a sound scientific basis, say PASS, the American Cancer Society and American Academy of Dermatology Association.
FDA's draft guidance on data for sunscreen ingredient GRASE determinations overly focuses on risks relative to benefits, potentially shortchanging consumers at a time of soaring skin cancer rates, according to manufacturers, physicians and public health advocates.
FDA extended the comment deadline through Feb. 23 and was pointed about soliciting feedback regarding its draft guidance...
“Today’s consumers, especially younger generations, are redefining personal care as preventive care,” argues Kenvue on the basis of its latest research into global consumer trends.
Circular Action Alliance, the Producer Responsibility Organization managing California’s EPR law, is urging single-use packaging producers subject to the law to register ahead of a November 15 deadline for reporting materials.
Launching Heather’s UTI Defense, firm partners with Oxford University in clinical trial comparing its supplement head-to-head with D-mannose, most commonly available dietary ingredient for UTI prevention
